01 1Implanin
02 1Implanin/Nexplanon
03 5Implanon/Nexplanon
04 3Nexplanon/Implanon NXT
05 5NuvaRing
Main Therapeutic Indication : Women's Healthcare
Currency : USD
2020 Revenue in Millions : 237
2019 Revenue in Millions : 879
Growth (%) : -73
Main Therapeutic Indication : Women's Healthcare
Currency : USD
2020 Revenue in Millions : 680
2019 Revenue in Millions : 787
Growth (%) : -14
Main Therapeutic Indication : Women's Healthcare
Currency : USD
2021 Revenue in Millions : 191
2020 Revenue in Millions : 236
Growth (%) : -19
Main Therapeutic Indication : Women's Healthcare
Currency : USD
2021 Revenue in Millions : 769
2020 Revenue in Millions : 680
Growth (%) : 13
Main Therapeutic Indication : Women's Health
Currency : USD
2022 Revenue in Millions : 173
2021 Revenue in Millions : 191
Growth (%) : -9
Main Therapeutic Indication : Women's Health
Currency : USD
2022 Revenue in Millions : 834
2021 Revenue in Millions : 769
Growth (%) : 8
Main Therapeutic Indication : Women's Health
Currency : USD
2023 Revenue in Millions : 830
2022 Revenue in Millions : 834
Growth (%) : 0
Main Therapeutic Indication : Women's Health
Currency : USD
2023 Revenue in Millions : 152
2022 Revenue in Millions : 173
Growth (%) : -12
Main Therapeutic Indication : Sexual Health
Currency : USD
2015 Revenue in Millions : 502
2014 Revenue in Millions : 588
Growth (%) : 17%
Main Therapeutic Indication : Sexual Health
Currency : USD
2014 Revenue in Millions : 24.60%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?
